Israel's new coronavirus czar a lockdown hawk

Nachman Ash  / Photo: Tamar Matsafi, Globes
Nachman Ash / Photo: Tamar Matsafi, Globes

Nachman Ash has been critical of Israel's slowness in imposing a second lockdown, saying 'lockdown skeptics distort the science'.

Within the next few days, Nachman Ash, a former chief medical officer of the IDF and head of the medicine division of health fund Maccabi Health Services, will take over as coronavirus project coordinator from Ronni Gamzu. While Gamzu returns to running Tel Aviv's Ichilov Hospital and leaves behind the decision making arena and the late-night cabinet meetings, his replacement in the job will formulate his own approach to dealing with the continuing coronavirus crisis. At this stage, it is not clear what authority he will have, and whether, like Gamzu, he too will serve as an external consultant with no powers of his own.

Ash's approach to the coronavirus pandemic is apparently different from that of Gamzu. Whereas Gamzu tried to keep the economy as open as possible and to put of the imposition of a lockdown until the hospitals raised the red flag, Ash supported a lockdown at an earlier stage. On his Twitter account in the past few months he has repeatedly said that there is proof that lockdown works, and claimed that "'lockdown skeptics' are distorting the science.' In an interview with Radio 103 FM in August, Ash was adamant that "the delay in making decisions is only making the situation worse," and said that "the people heading the fight against the coronavirus must present a united front to the public, which knows no peace of mind."

Ash supported Gamzu's traffic light plan of different rules for different areas depending on the local infection statistics, and said that unless it was implemented, a lockdown was unavoidable. At the end of August, despite the steep rise in the number of tests and the progress on the tracing system, Ash said, "We are not doing enough, we are not acting fast, and there is no sense of an emergency. The feeling is as though we are managing with this."

Asked whether politics was defeating medicine, Ash said forthrightly: "Certainly, big time. I don't think it's defeating medicine, but it is defeating the campaign against the coronavirus in its various aspects, including the economy."

Unlike Gamzu, who comes from a background of management of a major hospital and who in the past served as director general of the Ministry of Health, Ash has a wealth of experience in medicine but is not familiar with the innards of the Ministry of Health, the internal politics, and the delicate relationship with the politicians. Nevertheless, Ash comes from the field of public health, the first front on which patients are treated, and which is readying to deal with Covid-19 together with seasonal flu.

Ash's appointment comes at a time when the morbidity statistics are falling, perhaps deceptively. Fewer than 1,000 new patients a day have been identified over the past week. The percentage of confirmed cases out of those tested has dropped to below 4%. The decline was more rapid than the experts expected, although the relaxations of the lockdown have slowed the pace of decline and predictably raised the infection coefficient from 0.65 to 0.7.

The first challenge that Ash will have to meet is to influence Israel's plan for exiting lockdown, a plan that has so far not been fully discussed and approved even though steps have begun to reopen the economy.

Many people who know Ash and have worked alongside him say that his outstanding characteristic is his pleasant demeanor. Dr. Hagai Levine, an associate professor at the Hebrew University of Jerusalem’s Braun School of Public Health and Community Medicine and chairman of the Association of Public Health Physicians, said, "Ash is a professional, a leader, who initiates, plans, and executes. He led the campaign against the flu pandemic of 2010, demonstrating an impressive ability to translate the recommendations of the epidemiologists and the public health doctors into optimum implementation and to harness the decision makers at all levels."

Published by Globes, Israel business news - en.globes.co.il - on October 28, 2020

© Copyright of Globes Publisher Itonut (1983) Ltd. 2020

Nachman Ash  / Photo: Tamar Matsafi, Globes
Nachman Ash / Photo: Tamar Matsafi, Globes
Unframe founders credit: Yossi Yarom Israeli AI enterprise platform co Unframe raises $50m

Unframe’s turnkey AI solutions enable companies to solve any enterprise AI use case at scale with fully functional, customized AI solutions for businesses in a matter of hours, rather than months.

Combatica credit: Combatica Combatica launches next-gen VR AI training platform

The Israeli company's virtual reality platform includes 50 AI generated scenarios, seven maps and even situations for operating night vision.

Shekel credit: Shutterstock Vladirina 32 Shekel volatility after US tariffs announcement

The shekel is weakening sharply against the euro, which is gaining following the unveiling of Donald Trump's tariffs plan.

Minister of Finance Bezalel Smotrich credit: Noam Moskovitz Knesset Spokesperson Treasury assesses potential damage to Israel's US exports

Israel will be charged a higher tariff on its exports to the US - its biggest export customer - than Turkey and the UAE.

Iranian flag credit: Shutterstock Why inflation haunts Iran

With a month-on-month increase of 3.3% and an annual rate of 37.1%, inflation reflects the struggles of millions of Iranians.

APM merges with lawyers from Doron, Tikotzky Kantor, Gutman credit: Eyal Merilos APM merges with 12 lawyers from Doron, Tikotzky Kantor, Gutman

With the addition of these 12 lawyers, Amit Pollak Matalon & Co. will now have 135 lawyers.

US President Donald Trump credit: Reuters Sipa USA Israel on list as Trump unveils tariffs

Relatively low reciprocal tariffs will be imposed on Israeli goods sold in the US.

Deflated unicorn credit: Shutterstock Big Tech 50 reports more huge falls in startup valuations

Israeli R&D partnership Big Tech 50 reports that an investment of $2 million in Orcam made in 2021, shrank to just $31,000 at the end of 2024.

NextFerm technologies based on yeast credit: NextFerm Food-tech co NextFerm suspends operations

The company, which produces food ingredients in yeast without genetic engineering, cannot pay its debts and is seeking a buyer.

Minister of Finance Bezalel Smotrich credit: Shlomi Yosef OECD sees recovery in growth but high inflation

The OECD Israel Economic Survey 2025 recommends that the Israeli government take several restraining measures, in order to exit the economic storm created by the war.

Dano Ben-Hur credit: Dror Sithakol Statisticians contradict BoI on impact of housing finance deals

The Central Bureau of Statistics insists the impact of 20/80 buy now pay later financing deals on the real estate market and housing prices is minimal.

Governor of the Bank of Israel Amir Yaron  credit: Government Press Office Debt fears top Bank of Israel's concerns

Most unusually, Governor of the Bank of Israel Amir Yaron's press conference last week did not focus on inflation and the impending interest rate decision.

US President Donald Trump  credit: Reuters/Leah Millis Israel moves to avoid Trump's tariffs axe

Minister of Finance Bezalel Smotrich has signed an order canceling all tariffs on imports from the US. The impact will mostly be on agricultural produce.

Forbes Rich List credit: Shutterstock Maslowski Marcin Wiz founders ranked in Forbes 2025 Rich List

There are a few dozen Israelis listed in the 2025 Forbes Real-Time Billionaires List including Wiz founders Assaf Rappaport, Yinon Costica, Roy Reznik and Ami Luttwak.

SatixFy CEO Nir Barkan credit: Ariel Barkan Canada's MDA Space to buy Israeli satcom co SatixFy

MDA Space will pay $269 million for the Israeli company, including taking on a $76 million debt and a 75% premium on SatixFy's closing price on Nasdaq yesterday.

Raising dollars credit: Shutterstock Israeli startups raised over $1b in March

Israeli privately-held tech companies have raised $2.1 billion in the first three months of 2025, according to IVC-LeumiTech, up 24% from the corresponding quarter of 2024.

Twitter Facebook Linkedin RSS Newsletters גלובס Israel Business Conference 2018